KONINKLIJKE PHILIPS NVR- NY (PHG)

US5004723038

20.115  -0.2 (-0.96%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PHG. PHG was compared to 199 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHG have multiple concerns. PHG is valued quite cheap, while showing a decent growth score. This is a good combination!



2

1. Profitability

1.1 Basic Checks

PHG had positive earnings in the past year.
In the past year PHG had a positive cash flow from operations.
In multiple years PHG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PHG reported negative operating cash flow in multiple years.

1.2 Ratios

With a decent Return On Assets value of -6.87%, PHG is doing good in the industry, outperforming 60.10% of the companies in the same industry.
PHG has a Return On Equity of -16.72%. This is in the better half of the industry: PHG outperforms 61.62% of its industry peers.
Industry RankSector Rank
ROA -6.87%
ROE -16.72%
ROIC N/A
ROA(3y)3.25%
ROA(5y)3.65%
ROE(3y)6.95%
ROE(5y)7.83%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 41.75%, PHG is doing worse than 64.14% of the companies in the same industry.
In the last couple of years the Gross Margin of PHG has declined.
PHG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.48%

2

2. Health

2.1 Basic Checks

PHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for PHG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PHG has an Altman-Z score of 1.49. This is a bad value and indicates that PHG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PHG (1.49) is comparable to the rest of the industry.
The Debt to FCF ratio of PHG is 684.67, which is on the high side as it means it would take PHG, 684.67 years of fcf income to pay off all of its debts.
PHG has a Debt to FCF ratio of 684.67. This is in the better half of the industry: PHG outperforms 72.22% of its industry peers.
PHG has a Debt/Equity ratio of 0.59. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. PHG is outperformed by 70.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 684.67
Altman-Z 1.49
ROIC/WACCN/A
WACC6.26%

2.3 Liquidity

PHG has a Current Ratio of 1.20. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
PHG has a Current ratio of 1.20. This is amonst the worse of the industry: PHG underperforms 89.39% of its industry peers.
A Quick Ratio of 0.69 indicates that PHG may have some problems paying its short term obligations.
PHG's Quick ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 90.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.69

4

3. Growth

3.1 Past

The earnings per share for PHG have decreased by -7.94% in the last year.
The earnings per share for PHG have been decreasing by -11.60% on average. This is quite bad
PHG shows a small growth in Revenue. In the last year, the Revenue has grown by 6.83%.
The Revenue has been growing slightly by 0.05% on average over the past years.
EPS 1Y (TTM)-7.94%
EPS 3Y-22.11%
EPS 5Y-11.6%
EPS growth Q2Q100%
Revenue 1Y (TTM)6.83%
Revenue growth 3Y1.3%
Revenue growth 5Y0.05%
Revenue growth Q2Q7.01%

3.2 Future

The Earnings Per Share is expected to grow by 19.83% on average over the next years. This is quite good.
Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y37.55%
EPS Next 2Y23.44%
EPS Next 3Y22.33%
EPS Next 5Y19.83%
Revenue Next Year6.54%
Revenue Next 2Y5.16%
Revenue Next 3Y5.02%
Revenue Next 5Y5.49%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.09, PHG is valued correctly.
Based on the Price/Earnings ratio, PHG is valued cheaply inside the industry as 90.40% of the companies are valued more expensively.
PHG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.18.
The Price/Forward Earnings ratio is 12.90, which indicates a correct valuation of PHG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 95.96% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PHG to the average of the S&P500 Index (21.51), we can say PHG is valued slightly cheaper.
Industry RankSector Rank
PE 16.09
Fwd PE 12.9

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 81.31% of the companies listed in the same industry.
PHG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHG is cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1407.69
EV/EBITDA 20.98

4.3 Compensation for Growth

PHG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHG's earnings are expected to grow with 22.33% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y23.44%
EPS Next 3Y22.33%

0

5. Dividend

5.1 Amount

No dividends for PHG!.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (2/20/2024, 9:35:08 AM)

20.115

-0.2 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.20B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.09
Fwd PE 12.9
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.43
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.87%
ROE -16.72%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 0.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-7.94%
EPS 3Y-22.11%
EPS 5Y
EPS growth Q2Q
EPS Next Y37.55%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.83%
Revenue growth 3Y1.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y